Trial intelligence / Profile preview

Comparison of BM-MSC vs UC-MSC for HBV-related Liver Failure

NCT01844063Phase 2Unknown

Sponsor
The Third Affiliated Hospital of Sun Yat-sen University
Start
Jul 2013
Primary completion
Jan 2016
Modality
Stem Cell Therapies
Countries
1
01

Overview

A Phase 2 trial of bone marrow-derived mesenchymal stem cells, human umbilical cord mesenchymal stem cells in liver failure, sponsored by The Third Affiliated Hospital of Sun Yat-sen University. Status: unknown.

02

Drugs

bone marrow-derived mesenchymal stem cellshuman umbilical cord mesenchymal stem cells
03

Conditions

liver failure

Beyond the preview

Go deeper on NCT01844063.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01844063.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call